Nefazodone-induced hypoglycemia in a diabetic patient with major depression.
Warnock
J K
JK
Biggs
F
F
D018687:Antidepressive Agents, Second-Generation / Q000009:adverse effects* / Q000627:therapeutic use; D001786:Blood Glucose / Q000187:drug effects; D003866:Depressive Disorder / Q000097:blood / Q000150:complications / Q000188:drug therapy*; D003922:Diabetes Mellitus, Type 1 / Q000097:blood / Q000150:complications*; D003924:Diabetes Mellitus, Type 2 / Q000150:complications; D005260:Female; D006801:Humans; D007003:Hypoglycemia / Q000139:chemically induced*; D008875:Middle Aged; D010879:Piperazines; D014230:Triazoles / Q000009:adverse effects* / Q000627:therapeutic use
D018687:Antidepressive Agents, Second-Generation; D001786:Blood Glucose; D010879:Piperazines; D014230:Triazoles; C051752:nefazodone